Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (341-350 of 755) with videos related to

Pageof 76
Sort By:
Clinical and Experimental Rheumatology|September 24, 2009
Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registryD E Furst, H Chang, J D Greenberg, et al.
Arthritis Care & Research|October 9, 2018
Long-Term Safety of Rituximab in Rheumatoid Arthritis: Analysis From the SUNSTONE RegistryKevin L Winthrop, Kenneth Saag, Matthew D Cascino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2000
Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunityN C Lambert, P C Evans, T L Hashizumi, et al.
Arthritis Research & Therapy|August 18, 2018
High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable differenceHongyan Li, Daniel E Furst, Hongtao Jin, et al.
Arthritis and Rheumatism|June 26, 2008
Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled studyMichael E Weinblatt, Michael H Schiff, Eric M Ruderman, et al.
The Journal of Rheumatology|October 10, 2008
Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosisYolanda Braun-Moscovici, Daniel E Furst, Doron Markovits, et al.
Arthritis Care & Research|February 22, 2011
Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registryDaniel E Furst, Aileen L Pangan, Leslie R Harrold, et al.
Clinical Pharmacology and Therapeutics|August 1, 1988
Serum concentration and dose-response relationships for carprofen in rheumatoid arthritisD E Furst, J R Caldwell, M P Klugman, et al.
Clinical and Experimental Rheumatology|September 1, 2020
Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trialsCosimo Bruni, Donald P Tashkin, Virginia Steen, et al.
Arthritis and Rheumatism|July 27, 2012
Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trialsSimon Tarp, Else M Bartels, Henning Bliddal, et al.
Pageof 76

Showing results (341-350 of 755) with videos related to

Sort By:
Pageof 76
Clinical and Experimental Rheumatology|September 24, 2009
Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registryD E Furst, H Chang, J D Greenberg, et al.
Arthritis Care & Research|October 9, 2018
Long-Term Safety of Rituximab in Rheumatoid Arthritis: Analysis From the SUNSTONE RegistryKevin L Winthrop, Kenneth Saag, Matthew D Cascino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2000
Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunityN C Lambert, P C Evans, T L Hashizumi, et al.
Arthritis Research & Therapy|August 18, 2018
High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable differenceHongyan Li, Daniel E Furst, Hongtao Jin, et al.
Arthritis and Rheumatism|June 26, 2008
Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled studyMichael E Weinblatt, Michael H Schiff, Eric M Ruderman, et al.
The Journal of Rheumatology|October 10, 2008
Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosisYolanda Braun-Moscovici, Daniel E Furst, Doron Markovits, et al.
Arthritis Care & Research|February 22, 2011
Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registryDaniel E Furst, Aileen L Pangan, Leslie R Harrold, et al.
Clinical Pharmacology and Therapeutics|August 1, 1988
Serum concentration and dose-response relationships for carprofen in rheumatoid arthritisD E Furst, J R Caldwell, M P Klugman, et al.
Clinical and Experimental Rheumatology|September 1, 2020
Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trialsCosimo Bruni, Donald P Tashkin, Virginia Steen, et al.
Arthritis and Rheumatism|July 27, 2012
Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trialsSimon Tarp, Else M Bartels, Henning Bliddal, et al.
Pageof 76